Cargando…
Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis
The activation and dysregulation of retrotransposons has been identified in the CNS of individuals with the fatal neurodegenerative disorder Amyotrophic lateral sclerosis (ALS). This includes elements from multiple different families and subfamilies of retrotransposons, however there is limited know...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961898/ https://www.ncbi.nlm.nih.gov/pubmed/35346298 http://dx.doi.org/10.1186/s13041-022-00914-x |
_version_ | 1784677686675767296 |
---|---|
author | Pfaff, Abigail L. Bubb, Vivien J. Quinn, John P. Koks, Sulev |
author_facet | Pfaff, Abigail L. Bubb, Vivien J. Quinn, John P. Koks, Sulev |
author_sort | Pfaff, Abigail L. |
collection | PubMed |
description | The activation and dysregulation of retrotransposons has been identified in the CNS of individuals with the fatal neurodegenerative disorder Amyotrophic lateral sclerosis (ALS). This includes elements from multiple different families and subfamilies of retrotransposons, however there is limited knowledge of the specific loci from which this expression occurs in ALS. The long interspersed element-1 (L1) is the only autonomous retrotransposon in the human genome and members of this family of elements maintain the ability to mobilise. Despite L1s contributing to 17% of the human genome only 80–100 L1s encode the required proteins for mobilisation and are retrotransposition competent. Identifying the specific loci from which L1 expression occurs will inform on the potential functional consequences of their expression, such as the potential for somatic retrotransposition or DNA damage caused by the endonuclease activity of the ORF2 protein of the L1. Here we characterised L1 loci expression using the L1EM tool (https://github.com/FenyoLab/L1EM) in RNA sequencing data from 518 samples across four tissues (motor cortex, frontal cortex, cerebellum and cervical spinal cord) in the Target ALS cohort obtained from the New York Genome Center. There was a significant reduction in total intact L1 expression (those that encode functional proteins) in two brain regions of individuals with ALS compared to controls and clustering of the ALS brain regions occurred based on their intact L1 expression profile. Although overall the levels of L1 expression were reduced in ALS/ALS with other neurological disorder (ND) there were individuals in which L1s were expressed at much higher levels than the rest of the ALS/ALSND cohort. Expressed L1 loci were more frequently located in introns compared to those not expressed and the level of L1 expression positively correlated with the expression of the gene in which it was located. Significant differences were observed in the expression profiles of L1s in ALS and specific features of these elements, such as location in the genome and whether or not they are intact, were significantly associated with those that were expressed in the cohort. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13041-022-00914-x. |
format | Online Article Text |
id | pubmed-8961898 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89618982022-03-30 Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis Pfaff, Abigail L. Bubb, Vivien J. Quinn, John P. Koks, Sulev Mol Brain Research The activation and dysregulation of retrotransposons has been identified in the CNS of individuals with the fatal neurodegenerative disorder Amyotrophic lateral sclerosis (ALS). This includes elements from multiple different families and subfamilies of retrotransposons, however there is limited knowledge of the specific loci from which this expression occurs in ALS. The long interspersed element-1 (L1) is the only autonomous retrotransposon in the human genome and members of this family of elements maintain the ability to mobilise. Despite L1s contributing to 17% of the human genome only 80–100 L1s encode the required proteins for mobilisation and are retrotransposition competent. Identifying the specific loci from which L1 expression occurs will inform on the potential functional consequences of their expression, such as the potential for somatic retrotransposition or DNA damage caused by the endonuclease activity of the ORF2 protein of the L1. Here we characterised L1 loci expression using the L1EM tool (https://github.com/FenyoLab/L1EM) in RNA sequencing data from 518 samples across four tissues (motor cortex, frontal cortex, cerebellum and cervical spinal cord) in the Target ALS cohort obtained from the New York Genome Center. There was a significant reduction in total intact L1 expression (those that encode functional proteins) in two brain regions of individuals with ALS compared to controls and clustering of the ALS brain regions occurred based on their intact L1 expression profile. Although overall the levels of L1 expression were reduced in ALS/ALS with other neurological disorder (ND) there were individuals in which L1s were expressed at much higher levels than the rest of the ALS/ALSND cohort. Expressed L1 loci were more frequently located in introns compared to those not expressed and the level of L1 expression positively correlated with the expression of the gene in which it was located. Significant differences were observed in the expression profiles of L1s in ALS and specific features of these elements, such as location in the genome and whether or not they are intact, were significantly associated with those that were expressed in the cohort. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13041-022-00914-x. BioMed Central 2022-03-28 /pmc/articles/PMC8961898/ /pubmed/35346298 http://dx.doi.org/10.1186/s13041-022-00914-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Pfaff, Abigail L. Bubb, Vivien J. Quinn, John P. Koks, Sulev Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis |
title | Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis |
title_full | Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis |
title_fullStr | Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis |
title_full_unstemmed | Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis |
title_short | Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis |
title_sort | locus specific reduction of l1 expression in the cortices of individuals with amyotrophic lateral sclerosis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961898/ https://www.ncbi.nlm.nih.gov/pubmed/35346298 http://dx.doi.org/10.1186/s13041-022-00914-x |
work_keys_str_mv | AT pfaffabigaill locusspecificreductionofl1expressioninthecorticesofindividualswithamyotrophiclateralsclerosis AT bubbvivienj locusspecificreductionofl1expressioninthecorticesofindividualswithamyotrophiclateralsclerosis AT quinnjohnp locusspecificreductionofl1expressioninthecorticesofindividualswithamyotrophiclateralsclerosis AT kokssulev locusspecificreductionofl1expressioninthecorticesofindividualswithamyotrophiclateralsclerosis |